Filter posts

ICER Comes Under Renewed Scrutiny

As we enter a new and exciting era of medicine, there is an important question …

Value Assessment Tools that take “Precision” out of “Precision Medicine” are Harmful to Pati...

The conversation about health care costs is front and center in Washington, and new data …

A New Approach to Assessing Value in Health Care

It’s an important and exciting time in the biotech industry. Spending on prescription drugs has …

ICYMI: Jim Greenwood Weighs In on the Future of Drug Pricing

Rewarding for quality – not quantity – is becoming more and more common in health …

MassBio Releases Statement Following Cost Trends Hearings

MassBio issues this statement, following the Massachusetts’ Health Policy Commission’s (HPC) hearing earlier this week on …